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3-Year Outcomes From Patients With Unprotected Left Main Stenting
The procedural success rates and long-term outcomes after drug-eluting stent(DES) implantation for unprotected leftmain coronary artery (ULMCA) disease
are unclear. This retrospective registry reports the results from over 300 patients who
underwent percutaneous coronary intervention with DES for ULMCA lesions, who
had a minimum follow-up of 3 years. Cardiac death occurred in 9.2% of patients
during the 3 years, but in only 6.2% of elective cases. The target lesion revasculariza-
tion rate was under 6%. These data suggest that ULMCA stenting with DES is
emerging as a viable alternative to coronary artery bypass grafting in select patients.
See page 2212.
Interventional Cardiology
Longer Clopidogrel Use Improves
Outcomes for Diabetic Patients With BMS and DES
Brar and colleagues identified over 700 diabetic patients who underwent stentimplantationwith either bare-metal stents (BMS) or drug-eluting stents (DES) to
determine if long-term outcomes differed between stent type and by duration of
clopidogrel use. The risk of death or myocardial infarction (MI) was 5 times higher in
those who used clopidogrel for 6 months compared with 9 months. Among
clopidogrel nonusers (6months of use), the incidence of death andMI did not differ
by stent type. These results suggest that clopidogrel should be used for at least 1 year in
diabetics undergoing stent implantation regardless of whether the stent is a BMS or
DES. See pages 2220 and 2228.
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Cardiac MR in Infarction
Post-STEMI Microvascular Injury Can Be
Quantified With CMR or Intracoronary Doppler Flow
Hirsch and colleagues compared the severity of microvascular obstruction (MO)measured by cardiovascular magnetic resonance (CMR) and intracoronary
Doppler flow measurements. Subjects had been treated with primary percutaneous
coronary intervention for anterior ST-segment elevation myocardial infarction
(STEMI) 4 to 8 days earlier. Using a Doppler guidewire, several markers of decreased
tissueperfusion, including early systolic retrogradeflow, anddiastolic decelerationwere
more likely to be abnormal in patients withMO on CMR. These results demonstrate
that there is a good correlation between CMR and intracoronary Doppler measure-
ments for determining the extent of microvascular injury. See pages 2230 and
2239. See figure.
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Arrhythmias in
Cardiac Transplants
Frequency of Supraventricular Arrhythmias After Heart Transplantation
Vaseghi and colleagues reviewed over 700 patients who underwent orthotopicheart transplantation (OHT) to understand the incidence, mechanisms, and
management of supraventricular tachycardia (SVT) after OHT. Some SVTs were due
to abnormalities in the donor heart, while others occurred near the suture lines or were
typical isthmus-dependent flutter. Atrial fibrillation occurred only in the perioperative
period or in patients with acute rejection or transplant vasculopathy. The majority of
SVTs in OHT patients appear amenable to catheter ablation; atrial fibrillation in this
population should prompt an evaluation for acute rejection and/or vasculopathy.
See page 2241. See figure.
